TherapeuticsMD (TXMD) EBT Margin Growth (1y) (2012 - 2026)
TherapeuticsMD (TXMD) EBT Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | -3,838.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,838.00 |
| Mar 31, 2026 | 18,420.00 |
| Dec 31, 2025 | -7,739.00 |
| Sep 30, 2025 | 11,003.00 |
| Jun 30, 2025 | 50,597.00 |
| Mar 31, 2025 | 8,849.00 |
| Dec 31, 2024 | 35,018.00 |
| Sep 30, 2024 | 260,200.00 |
| Jun 30, 2024 | 10,368.00 |
| Mar 31, 2024 | 29,682.00 |
| Dec 31, 2023 | -40,841.00 |
| Sep 30, 2023 | 142,739.00 |
| Jun 30, 2023 | 372,145.00 |
| Mar 31, 2023 | 201,665.00 |
| Dec 31, 2022 | -19,783.00 |
| Sep 30, 2022 | -394,640.00 |
| Jun 30, 2022 | -408,842.00 |
| Mar 31, 2022 | -237,370.00 |
| Dec 31, 2021 | 45,490.00 |
| Sep 30, 2021 | -1,804.00 |